Notice: refund approved | Dec 10, 2021 | PAPER | BOARD |
Petitioner's Request for Refund | Dec 8, 2021 | PAPER | PETITIONER |
Order: on Motion for Pro Hac Vice Admission of Eric M. Majchrzak | Oct 6, 2021 | PAPER | BOARD |
Institution Decision: Deny | Oct 6, 2021 | PAPER | BOARD |
Petitioner's Mot. for Pro Hac Vice of E. Majchrzak | Sep 10, 2021 | PAPER | PETITIONER |
Exhibit 1038: PHV Decl. of E. Majchrzak | Sep 10, 2021 | EXHIBIT | PETITIONER |
Patent Owner's Sur-Reply in Support of Its Preliminary Response | Aug 24, 2021 | PAPER | PATENT OWNER |
Reply to Pat. Owner's Preliminary Response | Aug 10, 2021 | PAPER | PETITIONER |
Order - Granting Petitioners Request for Leave to File a Reply - 37 C.F.R. Sect. 42.5 | Jul 27, 2021 | PAPER | BOARD |
Ex. 3001 | Jul 27, 2021 | EXHIBIT | BOARD |
Passage Registration Statement (Form S-1) | Jul 9, 2021 | EXHIBIT | PATENT OWNER |
Passage (Form S-1 Amendment No. 2) | Jul 9, 2021 | EXHIBIT | PATENT OWNER |
Passage Form 10K | Jul 9, 2021 | EXHIBIT | PATENT OWNER |
Wilson Consulting Agreement | Jul 9, 2021 | EXHIBIT | PATENT OWNER |
Penn-Passage License Agreement | Jul 9, 2021 | EXHIBIT | PATENT OWNER |
University of Pennsylvania Gene Therapy Program - James Wilson, MD, PhD | Jul 9, 2021 | EXHIBIT | PATENT OWNER |
Passage Bio - Company - About Passage Bio | Jul 9, 2021 | EXHIBIT | PATENT OWNER |
Passage Bio - Company - Leadership Team | Jul 9, 2021 | EXHIBIT | PATENT OWNER |
Passage Bio - Company - Board of Directors - James Wilson | Jul 9, 2021 | EXHIBIT | PATENT OWNER |
Cross (2019) | Jul 9, 2021 | EXHIBIT | PATENT OWNER |
Declaration of James M. Wilson | Jul 9, 2021 | EXHIBIT | PATENT OWNER |
Declaration of Dr. Karen Kozarsky | Jul 9, 2021 | EXHIBIT | PATENT OWNER |
Second Declaration of Dr. Karen Kozarsky | Jul 9, 2021 | EXHIBIT | PATENT OWNER |
De (2005) | Jul 9, 2021 | EXHIBIT | PATENT OWNER |
Cearley (2008) | Jul 9, 2021 | EXHIBIT | PATENT OWNER |
Limberis (2008) | Jul 9, 2021 | EXHIBIT | PATENT OWNER |
Vandenberghe (2009) | Jul 9, 2021 | EXHIBIT | PATENT OWNER |
Clinical Trials.gov NCT04713475 | Jul 9, 2021 | EXHIBIT | PATENT OWNER |
Clinical Trials.gov NCT04771416 | Jul 9, 2021 | EXHIBIT | PATENT OWNER |
US 20200056159 | Jul 9, 2021 | EXHIBIT | PATENT OWNER |
'043 appl FH excerpts | Jul 9, 2021 | EXHIBIT | PATENT OWNER |
'918 appl FH excerpts | Jul 9, 2021 | EXHIBIT | PATENT OWNER |
'600 app FH excerpts | Jul 9, 2021 | EXHIBIT | PATENT OWNER |
'322 app FH excerpts | Jul 9, 2021 | EXHIBIT | PATENT OWNER |
Johnson Declaration | Jul 9, 2021 | EXHIBIT | PATENT OWNER |
2021-07-09 Patent Owner's Preliminary Response to Petition | Jul 9, 2021 | PAPER | PATENT OWNER |
Patent Owner's Mandatory Notices | Apr 20, 2021 | PAPER | PATENT OWNER |
Patent Owner's Power of Attorney | Apr 20, 2021 | PAPER | PATENT OWNER |
Power of Attorney of REGENXBIO Inc | Apr 20, 2021 | PAPER | PATENT OWNER |
Notice of Accord Filing Date | Apr 9, 2021 | PAPER | BOARD |
Exhibit 1001: U.S. Patent No. 10,695,441 | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1002: File History of U.S. Patent No. 10,695,441 (Part 1 of 7) | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1002: Part 2 of 7 | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1002: Part 3 of 7 | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1002: Part 4 of 7 | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1002: Part 5 of 7 | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1002 Part 6 of 7 | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1002: Part 7 of 7 | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1004: Ponnazhagan et al., Adeno-Associated Virus for Cancer Gene Therapy, 61 CANCER RESEARCH 6313 (2001) | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1005: Xie et al., The Atomic Structure of Adeno-Associated Virus (AAV-2), a Vector for Human Gene Therapy, 99 PNAS 10405 (2002) | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1006: Joseph E. Rabinowitz & R. Jude Samulski, Building a Better Vector: The Manipulation of AAV Virions, 278 VIROLOGY 301 (2000) | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1007: Wu et al., Mutational Analysis of the Adeno-Associated Virus Type 2 (AAV2) Capsid Gene and Construction of AAV2 Vectors with Altered Tropism, 74 JOURNAL OF VIROLOGY 8635 (2000) | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1008: Sonntag, et al., The Assembly-Activating Protein Promotes Capsid Assembly of Different Adeno-Associated Virus Serotypes, 85 JOURNAL OF VIROLOGY 12686 (2011) | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1009: Hildegard Buning & Arun Srivastava, Capsid Modifications for Targeting and Improving the Efficacy of AAV Vectors, 12 MOLECULAR THERAPY: METHODS & CLINICAL DEVELOPMENT 248 (2019) | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1010: U.S. Patent No. 10,265,417 | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1011: File History of U.S. Patent No. 10,265,417 (Part 1 of 6) | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1011: Part 2 of 6 | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1011: Part 3 of 6 | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1011: Part 4 of 6 | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1011: Part 5 of 6 | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1011: Part 6 of 6 | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1012: Kei Adachi et al., Drawing a High-Resolution Functional Map of Adeno-Associated Virus Capsid by Massively Parallel Sequencing, 5 NATURE COMMUNICATIONS 3075 (2014) | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1013: Esther J. Lee et al., Adeno-Associated Virus (AAV) Vectors: Rational Design Strategies for Capsid Engineering, 7 CURR. OPIN. BIOMED. ENG. 58 (2018) | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1014: U.S. Application No. 16/149,218 | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1015: U.S. Application No. 13/023,918 | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1016: U.S. Application No. 15/227,418 | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1017: U.S. Application No. 16/045,043 | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1018: U.S. Patent No. 9,677,088 | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1019: U.S. Patent No. 7,906,111 | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1020: U.S. Patent No. 8,734,809 | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1021: Joseph E. Rabinowitz et al., Insertional Mutagenesis of AAV2 Capsid and the Production of Recombinant Virus, 265 JOURNAL OF VIROLOGY 274 (1999) | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1022: Maxim Salganik et al., Adeno-Associated Virus Capsid Proteins May Play a Role in Transcription and Second-Strand Synthesis of Recombinant Genomes, 88 JOURNAL OF VIROLOGY 1071 (2014) | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1023: William S.J. Valdar, Scoring Residue Conservation, 48 PROTEINS: STRUCTURE, FUNCTION, AND GENETICS 227 (2002) | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1024: Drew H. Bryant et al., Deep Diversification of an AAV Capsid Protein by Machine Learning, NATURE BIOTECHNOLOGY (2021) | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1025: U.S. Provisional Application No. 60/508,226 | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1026: U.S. Provisional Application No. 60/566,546 | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1027: Supplemental Data for Adachi et al., Drawing a High-Resolution Functional Map of A deno-Associated Virus Capsid by Massively Parallel Sequencing, 5 NATURE COMMUNICATIONS 3075 (2014) (excerpted) | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1029: Griffiths, AJF et al., How DNA Changes Affect Phenotype, AN INTRODUCTION TO GENETIC ANALYSIS (7th ed.) (2000) | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1030: John Carl Villanueva, How Many Atoms Are There in the Universe?, UNIVERSE TODAY (July 30, 2009) | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1031: U.S. Patent No. 9,737,618 | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1032: U.S. Publication No. 2015/0315612 | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1033: U.S. Publication No. 2007/0036760 | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1034: PCT Application No. PCT/US2004/028817 | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1035: Sequence Listing of U.S. Patent No. 8,734,809 | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1036: Curriculum Vitae of Mark Kay, M.D., Ph.D. | Mar 30, 2021 | EXHIBIT | PETITIONER |
Exhibit 1037: Declaration of David K. Tellekson | Mar 30, 2021 | EXHIBIT | PETITIONER |
Petitioner Passage Bio, Inc.'s Power of Attorney Pursuant to 37 C.F.R. Section 42.10(b) | Mar 30, 2021 | PAPER | PETITIONER |
Petition for Post Grant Review | Mar 30, 2021 | PAPER | PETITIONER |
Exhibit 1003: Expert Declaration of Mark Kay, M.D., Ph.D. | Mar 30, 2021 | EXHIBIT | PETITIONER |